Abrégé

The present invention relates to a composition for preventing, alleviating or treating cancer metastasis containing coffee, a coffee extract and a coffee by-product as an active ingredient. The composition is able to inhibit cancer metastasis, cancer growth, and VCAM1 protein expression, and thus may be used to prevent or treat cancer.

Classes IPC  ?

• A61K 36/74 - Rubiaceae (famille de la garance)
• A61P 35/04 - Agents anticancéreux spécifiques pour le traitement des métastases

Abrégé

The present invention relates to a method of providing an efficient artificial intelligence service in a multi-device environment, and the method may comprise the steps in which: a) a terminal evaluates the hardware performance of the terminal, an edge device, and a cloud server and configures a ratio as the result of the evaluation; b) the terminal calculates the characteristic of an artificial intelligence service model; c) the terminal adjusts the configured hardware evaluation result ratio of the terminal, the edge device, and the cloud server according to the calculated characteristic of the artificial intelligence service model; and d) the adjusted result is determined as a task offloading policy and all tasks are distributed to and processed in the terminal, the edge device, and the cloud server according to the task offloading policy.

Classes IPC  ?

• G06F 9/50 - Allocation de ressources, p.ex. de l'unité centrale de traitement [UCT]
• H04L 67/50 - Services réseau
• H04L 67/10 - Protocoles dans lesquels une application est distribuée parmi les nœuds du réseau
• H04L 67/289 - Traitement intermédiaire fonctionnellement situé à proximité de l'application consommatrice de données, p.ex. dans la même machine, dans le même domicile ou dans le même sous-réseau

Abrégé

An etching processing apparatus and an etching processing method using a liquid fluorocarbon or a liquid hydrofluorocarbon precursor are proposed, the etching processing apparatus and etching processing method capable of achieving almost the same effect as cryogenic etching even at a relatively high temperature compared to cryogenic etching. In addition, an etching processing apparatus and an etching processing method capable of solving process problems that may arise due to a liquid precursor and a low temperature may be provided.

Classes IPC  ?

• H01L 21/3065 - Gravure par plasma; Gravure au moyen d'ions réactifs
• H01J 37/32 - Tubes à décharge en atmosphère gazeuse

Abrégé

Proposed are a method and a system for removing L-FC in a plasma etching process, in which L-FC, which is condensed on a wafer, an electrode, a substrate, a head, or the like, is removed by using infrared or ultraviolet rays in a plasma etching process using an L-FC precursor.

Classes IPC  ?

• H01J 37/32 - Tubes à décharge en atmosphère gazeuse
• H01L 21/311 - Gravure des couches isolantes
• H01J 37/34 - Tubes à décharge en atmosphère gazeuse fonctionnant par pulvérisation cathodique
• H01L 21/02 - Fabrication ou traitement des dispositifs à semi-conducteurs ou de leurs parties constitutives
• B08B 7/00 - Nettoyage par des procédés non prévus dans une seule autre sous-classe ou un seul groupe de la présente sous-classe

Abrégé

According to an embodiment of the present invention, an etching processing apparatus and an etching processing method using a liquid fluorocarbon or a liquid hydrofluorocarbon precursor may be provided, the etching processing apparatus and etching processing method capable of achieving almost the same effect as cryogenic etching even at a relatively high temperature compared to cryogenic etching. In addition, an etching processing apparatus and an etching processing method capable of solving process problems that may arise due to a liquid precursor and a low temperature may be provided.

Classes IPC  ?

• H01L 21/67 - Appareils spécialement adaptés pour la manipulation des dispositifs à semi-conducteurs ou des dispositifs électriques à l'état solide pendant leur fabrication ou leur traitement; Appareils spécialement adaptés pour la manipulation des plaquettes pendant la fabrication ou le traitement des dispositifs à semi-conducteurs ou des dispositifs électriques à l'état solide ou de leurs composants

Abrégé

The present invention relates to a composition comprising coffee and a coffee extract and byproduct as an active ingredient for prevention of cancer metastasis or for alleviation or treatment of cancer. With inhibitory activity against cancer metastasis, cancer growth, and VCAM1 protein expression, the composition can be used for preventing or treating cancer.

Classes IPC  ?

• A61K 36/74 - Rubiaceae (famille de la garance)
• A61P 35/00 - Agents anticancéreux
• A61P 35/04 - Agents anticancéreux spécifiques pour le traitement des métastases

Abrégé

The present invention relates to a method and a system for removing L-FC in a plasma etching process, in which L-FC, which is condensed on a wafer, an electrode, a substrate, a head, etc., is removed by using infrared or ultraviolet rays in a plasma etching process using an L-FC precursor. This is advantageous in that L-FC neutral species and reaction by-products, which are adsorbed on the head, the electrode, the substrate, and the wafer, can be removed without affecting the conditions for a semiconductor-device manufacturing process.

Classes IPC  ?

• H01L 21/3065 - Gravure par plasma; Gravure au moyen d'ions réactifs
• H01L 21/311 - Gravure des couches isolantes
• H01L 21/67 - Appareils spécialement adaptés pour la manipulation des dispositifs à semi-conducteurs ou des dispositifs électriques à l'état solide pendant leur fabrication ou leur traitement; Appareils spécialement adaptés pour la manipulation des plaquettes pendant la fabrication ou le traitement des dispositifs à semi-conducteurs ou des dispositifs électriques à l'état solide ou de leurs composants
• H01J 37/32 - Tubes à décharge en atmosphère gazeuse

Abrégé

The present invention relates to a composition for preventing or treating depression or anxiety disorder, containing, as an active ingredient, a complex extract of Astragali Radix and Salviae Miltiorrhizae Radix, and can be pharmaceutically used for prevention, treatment or alleviation of depression or anxiety disorder, and can also be effectively used as a health functional food.

Classes IPC  ?

• A61K 36/481 - Astragalus (astragalus cicer)
• A61K 36/537 - Salvia (sauge)
• A61P 25/24 - Antidépresseurs
• A61P 25/22 - Anxiolytiques
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés

Abrégé

Aquilaria agallocha RoxburghAquilaria agallocha RoxburghAquilaria agallocha Roxburgh extract as an active ingredient according to the present invention exhibits antioxidant activity, inhibition of apoptosis of neuronal cells, inhibition of cranial nerve stress, neuronal cell protection, inhibition of the production of reactive oxygen species (ROS) in neuronal cells, decrease in phosphorylation level of extracellular signal-regulated kinases (ERK), inhibition of the production of nitric oxide (NO) in neuronal cells, and inhibition of DNA segmentation of neuronal cells. Accordingly, the composition has an effect on degenerative neurological diseases, such as Alzheimer's disease, Parkinson's disease, Lou Gehrig disease, Huntington's disease, multiple sclerosis, stroke, thrombosis, embolism, head trauma, metabolic disorder of cerebral circulation, brain functional coma or dementia, etc.

Classes IPC  ?

• A61K 36/835 - Aquilaria
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
• A61P 25/16 - Antiparkinsoniens
• A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p.ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence

Abrégé

The present invention relates to a composition for treatment or prevention of infectious inflammatory diseases, or a composition for immune enhancement, comprising a tryptophanyl-tRNA synthetase (TrpRS) as an active ingredient and, more specifically, to a pharmaceutical composition for treatment or prevention, a food composition for prevention or improvement, and a veterinary medical composition for prevention or treatment of inflammatory diseases caused by infection, the compositions comprising tryptophanyl-tRNA synthetase as an as active ingredient, and a composition for immune enhancement comprising tryptophanyl-tRNA synthetase as an as active ingredient. The composition of the present invention may be useful in preventing or treating diseases in humans and animals caused by infections from bacteria, viruses and the like, in particular, by activating the innate immune response to inhibit bacterial infections, viruses etc. in the early stage.

Classes IPC  ?

• A61K 38/53 - Ligases (6)
• C12N 9/00 - Enzymes, p.ex. ligases (6.); Proenzymes; Compositions les contenant; Procédés pour préparer, activer, inhiber, séparer ou purifier des enzymes

Abrégé

The present invention relates to a method of analyzing dust and a dust collecting apparatus used for the same, and more particularly, to a method of analyzing dust capable of adsorbing dust in the air using only an adhesive strength of a pad itself without using an additional power source and easily isolating the adsorbed dust particles to apply the dust particles to various analysis methods, and a dust collecting apparatus used for the same.

Classes IPC  ?

• G01N 1/22 - Dispositifs pour prélever des échantillons à l'état gazeux
• G01N 15/10 - Recherche de particules individuelles
• G01N 15/02 - Recherche de la dimension ou de la distribution des dimensions des particules
• G01N 23/00 - Recherche ou analyse des matériaux par l'utilisation de rayonnement [ondes ou particules], p.ex. rayons X ou neutrons, non couvertes par les groupes , ou
• G01N 27/62 - Recherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant les décharges électriques, p.ex. l'émission cathodique
• C12Q 1/02 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des micro-organismes viables
• B03C 3/32 - Ensembles transportables, p.ex. pour épurer l'air d'une pièce

Abrégé

Salvia Miltiorrhizae Radix as an active ingredient, the composition having a highly outstanding preventive or therapeutic effect in animal models simulating brain-tissue damage and brain dysfunction induced by acute and long-term excessive stress generated in actual clinical practice, which is effectively usable as a therapeutic agent thereof.

Classes IPC  ?

• A61K 36/481 - Astragalus (astragalus cicer)
• A61K 36/537 - Salvia (sauge)
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés

Abrégé

The present invention relates to a composition containing extracts of Artemisia iwayomogi and Curcuma longa for preventing, inhibiting, or treating obesity-related diseases. In particular, the composition according to the present invention has excellent antihyperlipidemic and antiatherogenic effects as well as an antiobesity effect, has an effect of simultaneously treating obesity, hyperlipidemia, and arteriosclerosis, and is free from side effects by containing a natural material as an active ingredient, and thus can be useful as an agent for preventing or treating obesity-related diseases.

Classes IPC  ?

• A61K 36/282 - Artemisia, p.ex. armoise
• A61K 36/9066 - Curcuma, p.ex. curcuma, zédoaire ou curcuma amada
• A61P 3/04 - Anorexigènes; Médicaments de l'obésité
• A61P 3/00 - Médicaments pour le traitement des troubles du métabolisme

Abrégé

The present invention relates to a composition for preventing or treating oxidative brain damage and brain dysfunction, the composition comprising Astragalus membranaceus and Salvia miltiorrhiza as active ingredients. The composition according to the present invention has a highly outstanding preventive or therapeutic effect in animal models simulating brain-tissue damage and brain dysfunction due to acute and long-term excessive stress as occurs in actual clinical practice.

Classes IPC  ?

• A61K 36/481 - Astragalus (astragalus cicer)
• A61K 36/537 - Salvia (sauge)
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux

Abrégé

The present invention relates to a composition containing a mixed herbal extract which is effective for treating and preventing allergic or non-allergic skin disease.

Classes IPC  ?

• A61K 36/88 - Liliopsida (monocotylédones)
• A61K 36/23 - Apiaceae ou Umbelliferae (famille de la carotte), p.ex. aneth, cerfeuil, coriandre ou cumin
• A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61Q 19/00 - Préparations pour les soins de la peau

Abrégé

The present invention relates to a drug which contains a herbal composition obtained by extraction from a composite herbal preparation composition which gives an improvement of at least 85.5% in the inhibition of β-amyloid protein production as compared a composition comprising prior art ratios, namely Acori gramineri Rhizoma, Polygala tenuifolia, Hoelen cum radix, Crataegi fructus and Morinda officinalis root; when the prior art ratios of Acori gramineri Rhizoma 2 : Polygala tenuifolia 2 : Hoelen cum radix 2 : Crataegi fructus 2 : Morinda officinalis root 2, are changed to Acori gramineri Rhizoma 4 : Polygala tenuifolia 4 or 2 : Hoelen cum radix 2 or 4 : Crataegi fructus 2 : Morinda officinalis root 2. The present invention makes it possible to provide a composite herbal preparation for inhibiting declining memory and treating dementia, which is derived from an outstanding natural composite herbal drug that does not elicit feelings of rejection on the part of the user and has no other side effects.

Classes IPC  ?

• A61K 36/882 - Acoraceae (famille de l'acore vrai), p.ex. acore vrai ou calame
• A61K 36/69 - Polygalaceae (famille du polygale)
• A61K 36/746 - Morinda
• A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p.ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence